BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McGonagle D, De Marco G, Bridgewood C. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection. J Autoimmun 2021;121:102662. [PMID: 34051613 DOI: 10.1016/j.jaut.2021.102662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Dalbeth N, Wallace ZS, Sparks JA, Li X, Zeng C, Wang Y, Xie D, Lei G, Wei J, Zhang Y. Risk of gout flares after COVID-19 vaccination: A case-crossover study. Seminars in Arthritis and Rheumatism 2022;56:152059. [DOI: 10.1016/j.semarthrit.2022.152059] [Reference Citation Analysis]
2 Franceschi AM, Petrover DR, Mcmahon TM, Libman RB, Giliberto L, Clouston SA, Castillo M, Kirsch C. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response. Clinical Imaging 2022;90:63-70. [DOI: 10.1016/j.clinimag.2022.06.020] [Reference Citation Analysis]
3 Chang CH, Kao SP, Ding DC. Transient ischemic attack after mRNA-based COVID-19 vaccination during pregnancy: A case report. World J Clin Cases 2022; 10(27): 9929-9935 [DOI: 10.12998/wjcc.v10.i27.9929] [Reference Citation Analysis]
4 Tondo G, Virgilio E, Naldi A, Bianchi A, Comi C. Safety of COVID-19 Vaccines: Spotlight on Neurological Complications. Life 2022;12:1338. [DOI: 10.3390/life12091338] [Reference Citation Analysis]
5 Rodríguez Y, Rojas M, Beltrán S, Polo F, Camacho-Domínguez L, Morales SD, Gershwin ME, Anaya JM. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun 2022;132:102898. [PMID: 36041291 DOI: 10.1016/j.jaut.2022.102898] [Reference Citation Analysis]
6 Al-Ahmad M, Al Rasheed M, Altourah L, Rodriguez-Bouza T, Shalaby N. Lupus anticoagulant activity and thrombosis post COVID-19 vaccination. Blood Coagul Fibrinolysis 2022. [PMID: 35946452 DOI: 10.1097/MBC.0000000000001161] [Reference Citation Analysis]
7 Marietta M, Coluccio V, Luppi M. Potential mechanisms of vaccine-induced thrombosis. Eur J Intern Med 2022:S0953-6205(22)00274-6. [PMID: 35953336 DOI: 10.1016/j.ejim.2022.08.002] [Reference Citation Analysis]
8 Baronti A, Gentile F, Manetti AC, Scatena A, Pellegrini S, Pucci A, Franzini M, Castiglione V, Maiese A, Giannoni A, Pistello M, Emdin M, Aquaro GD, Di Paolo M. Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? Viruses 2022;14:1644. [DOI: 10.3390/v14081644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bücke P, Hellstern V, Cimpoca A, Cohen JE, Horvath T, Ganslandt O, Bäzner H, Henkes H. Endovascular Treatment of Intracranial Vein and Venous Sinus Thrombosis—A Systematic Review. JCM 2022;11:4215. [DOI: 10.3390/jcm11144215] [Reference Citation Analysis]
10 Benvenuto D, Carnevale S, Giovanetti M, Ciccozzi M, Broccolo F. Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment. Semin Thromb Hemost 2022. [PMID: 35728600 DOI: 10.1055/s-0042-1744280] [Reference Citation Analysis]
11 Kolahchi Z, Khanmirzaei M, Mowla A. Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review. J Neurol Sci 2022;439:120327. [PMID: 35752132 DOI: 10.1016/j.jns.2022.120327] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang P, Tan F, Mu J, Chen H, Zhao X, Xu Y, Garcia V. Inhibitory Effect of Lactobacillus delbrueckii subsp. bulgaricus KSFY07 on Kappa-Carrageenan-Induced Thrombosis in Mice and the Regulation of Oxidative Damage. Cardiovascular Therapeutics 2022;2022:1-13. [DOI: 10.1155/2022/4415876] [Reference Citation Analysis]
13 Fratzke AP, van Schaik EJ, Samuel JE. Immunogenicity and Reactogenicity in Q Fever Vaccine Development. Front Immunol 2022;13:886810. [DOI: 10.3389/fimmu.2022.886810] [Reference Citation Analysis]
14 Ornelas-aguirre JM, Gómez-alcalá AV, Ramírez-leyva DH. Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 (AstraZeneca-Oxford) Vaccinated Individuals: A Systematic Review. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.03.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hosseinzadeh R, Barary M, Mehdinezhad H, Sio TT, Langer F, Khosravi S. Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccination. Res Pract Thromb Haemost 2022;6:e12750. [PMID: 35769629 DOI: 10.1002/rth2.12750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Scutelnic A, Brodard J, Kremer Hovinga JA, Arnold M, Heldner MR. Cerebral Venous Sinus Thrombosis Associated with Vaccine-Induced Thrombotic Thrombocytopenia—A Narrative Review. CTN 2022;6:11. [DOI: 10.3390/ctn6020011] [Reference Citation Analysis]
17 Long B, Bridwell R, Gottlieb M. Vaccine-induced immune thrombotic thrombocytopenia: why, what, who, and how? The American Journal of Emergency Medicine 2022. [DOI: 10.1016/j.ajem.2022.04.020] [Reference Citation Analysis]
18 Uzoigwe CE. Vaccine-induced thrombotic thrombocytopenia: Effect of E3 gene elimination from ds-DNA adenovirus vector? Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110864] [Reference Citation Analysis]
19 Panther EJ, Lucke-Wold B. Subarachnoid hemorrhage: management considerations for COVID-19. Explor Neuroprotective Ther 2022;2:65-73. [PMID: 35340712 DOI: 10.37349/ent.2022.00018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rzymski P, Fal A. To aspirate or not to aspirate? Considerations for the COVID-19 vaccines. Pharmacol Rep 2022. [PMID: 35320581 DOI: 10.1007/s43440-022-00361-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Uzun G, Pelzl L, Singh A, Bakchoul T. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia. Front Immunol 2022;13:837629. [PMID: 35273612 DOI: 10.3389/fimmu.2022.837629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Mungmunpuntipantip R, Wiwanitkit V. Comment on “Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story”. Metabolism Open 2022;13:100170. [DOI: 10.1016/j.metop.2022.100170] [Reference Citation Analysis]
23 Maiese A, Baronti A, Manetti AC, Di Paolo M, Turillazzi E, Frati P, Fineschi V. Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated? Vaccines 2022;10:308. [DOI: 10.3390/vaccines10020308] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
24 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Pang X, Liu H, He X, Ji T, Zhu Y, Cui Y. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2. Front Immunol 2021;12:782335. [PMID: 35095856 DOI: 10.3389/fimmu.2021.782335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Qiao J, Gardiner EE. Introduction to a review series "Biomarkers of Platelet Activation". Platelets 2022;:1-2. [PMID: 35107395 DOI: 10.1080/09537104.2022.2031949] [Reference Citation Analysis]
27 Ihnatko M, Truchla I, Ihnatková L, Prohászka Z, Lazúrová I. Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia. Front Med (Lausanne) 2021;8:789972. [PMID: 35059416 DOI: 10.3389/fmed.2021.789972] [Reference Citation Analysis]
28 Carnevale S, Giovanetti M, Benvenuto D, Ciccozzi M, Broccolo F. Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients? Semin Thromb Hemost 2022. [PMID: 35021248 DOI: 10.1055/s-0041-1742092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Curcio R, Gandolfo V, Alcidi R, Giacomino L, Campanella T, Casarola G, Rossi R, Chiatti L, D'abbondanza M, Commissari R, Gresele P, Pucci G, Vaudo G. VACCINE-INDUCED MASSIVE PULMONARY EMBOLISM AND THROMBOCYTOPENIA FOLLOWING A SINGLE DOSE OF JANSSEN AD26.COV2.S VACCINATION. Int J Infect Dis 2022:S1201-9712(21)01244-3. [PMID: 34986404 DOI: 10.1016/j.ijid.2021.12.345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Mao S, Fu L, Yin C, Liu X, Karimi-maleh H. The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review. RSC Adv 2022;12:22592-607. [DOI: 10.1039/d2ra04162f] [Reference Citation Analysis]
31 Roberge G, Carrier M. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia. Clin Appl Thromb Hemost 2022;28:10760296221086283. [PMID: 35275495 DOI: 10.1177/10760296221086283] [Reference Citation Analysis]
32 Asif S, Kesireddy M, Koepsell SA, Gonzalez-castellon MA, Gundabolu K, Baljevic M. Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject. The Neurohospitalist 2022;12:346-51. [DOI: 10.1177/19418744211055065] [Reference Citation Analysis]
33 Bilotta C, Perrone G, Adelfio V, Spatola GF, Uzzo ML, Argo A, Zerbo S. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis. Front Immunol 2021;12:729251. [PMID: 34912330 DOI: 10.3389/fimmu.2021.729251] [Reference Citation Analysis]
34 Ostrowski SR, Søgaard OS, Tolstrup M, Stærke NB, Lundgren J, Østergaard L, Hvas AM. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis. Front Immunol 2021;12:779453. [PMID: 34887867 DOI: 10.3389/fimmu.2021.779453] [Reference Citation Analysis]
35 Hana D, Patel K, Roman S, Gattas B, Sofka S. Clinical Cardiovascular Adverse Events Reported Post COVID-19 Vaccination: Are they a real risk? Curr Probl Cardiol 2021;:101077. [PMID: 34902392 DOI: 10.1016/j.cpcardiol.2021.101077] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Loo LK, Salim O, Liang D, Goel A, Sumangala S, Gowda AS, Davies B, Rajabally YA. Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom. Muscle Nerve 2021. [PMID: 34786740 DOI: 10.1002/mus.27461] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
37 Cleaver J, Ibitoye R, Morrison H, Flood R, Crewdson K, Marsh A, Abhinav K, Bosnell R, Crossley R, Mortimer A. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. J Neurointerv Surg 2021:neurintsurg-2021-018238. [PMID: 34782400 DOI: 10.1136/neurintsurg-2021-018238] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Piñar-Gutiérrez A, Remón-Ruiz P, Soto-Moreno A. Case report: Pituitary apoplexy after COVID-19 vaccination. Med Clin (Barc) 2021:S0025-7753(21)00640-0. [PMID: 34895747 DOI: 10.1016/j.medcli.2021.09.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Klok FA, Pai M, Huisman MV, Makris M. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol 2021:S2352-3026(21)00306-9. [PMID: 34774202 DOI: 10.1016/S2352-3026(21)00306-9] [Reference Citation Analysis]
40 Chang JC, Hawley HB. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas) 2021;57:1163. [PMID: 34833382 DOI: 10.3390/medicina57111163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 McLean-Tooke A, Lucas M, French M. Autoimmunity elicited by the chemokine response to adenovirus vector vaccines may underlie vaccine-induced immune thrombotic thrombocytopaenia: a hypothesis. Clin Transl Immunology 2021;10:e1349. [PMID: 34691454 DOI: 10.1002/cti2.1349] [Reference Citation Analysis]
42 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Reference Citation Analysis]
43 Di Micco P, Camporese G, Cardillo G, Lodigiani C, Carannante N, Annunziata A, Fiorentino G, Russo V, Imbalzano E. Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency. Medicina (Kaunas) 2021;57:997. [PMID: 34684034 DOI: 10.3390/medicina57100997] [Reference Citation Analysis]
44 Haimei MA. Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination. Clin Appl Thromb Hemost 2021;27:10760296211040110. [PMID: 34541935 DOI: 10.1177/10760296211040110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ali MAM. Editorial commentary: The platelet in COVID-19: A critical participant or a bystander? Trends Cardiovasc Med 2022;32:10-1. [PMID: 34534650 DOI: 10.1016/j.tcm.2021.09.004] [Reference Citation Analysis]
46 Datta P, Zhang F, Dordick JS, Linhardt RJ. Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia. Thromb J 2021;19:66. [PMID: 34526009 DOI: 10.1186/s12959-021-00318-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Marchandot B, Curtiaud A, Trimaille A, Sattler L, Grunebaum L, Morel O, Li N. Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions. European Heart Journal Open 2021;1:oeab014. [DOI: 10.1093/ehjopen/oeab014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
48 Azzarone B, Veneziani I, Moretta L, Maggi E. Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal. Front Immunol 2021;12:728513. [PMID: 34484238 DOI: 10.3389/fimmu.2021.728513] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Iba T, Levy JH. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends Cardiovasc Med 2021:S1050-1738(21)00096-7. [PMID: 34455073 DOI: 10.1016/j.tcm.2021.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
50 Schmidt J, Blessing F, Gürtler L. [SARS-CoV-2 vaccines and reaction of the immune system. Can the epidemic spread of the virus be prevented by vaccination?]. Dtsch Med Wochenschr 2021;146:1085-90. [PMID: 34416777 DOI: 10.1055/a-1550-0001] [Reference Citation Analysis]
51 Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID. Int J Mol Sci 2021;22:8255. [PMID: 34361021 DOI: 10.3390/ijms22158255] [Reference Citation Analysis]
52 Gürtler L, Seitz R, Schramm W. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine? Infection 2021. [PMID: 34286453 DOI: 10.1007/s15010-021-01658-x] [Reference Citation Analysis]
53 MacIntyre CR, Veness B, Berger D, Hamad N, Bari N. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia. Vaccine 2021;39:4784-7. [PMID: 34272095 DOI: 10.1016/j.vaccine.2021.07.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines 2021;:1-9. [PMID: 34176415 DOI: 10.1080/14760584.2021.1949294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Marcucci R, Marietta M. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Intern Emerg Med 2021;16:1113-9. [PMID: 34191218 DOI: 10.1007/s11739-021-02793-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Dutta A, Ghosh R, Bhattacharya D, Bhat S, Ray A, Pandit A, Das S, Dubey S. Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation. Diabetes Metab Syndr 2021;15:102184. [PMID: 34186376 DOI: 10.1016/j.dsx.2021.06.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
57 Ameratunga R, Longhurst H, Steele R, Lehnert K, Leung E, Brooks AES, Woon ST. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00702-9. [PMID: 34182162 DOI: 10.1016/j.jaip.2021.06.019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;:1-16. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Reference Citation Analysis]
59 Migliore L, Nicolì V, Stoccoro A. Gender Specific Differences in Disease Susceptibility: The Role of Epigenetics. Biomedicines 2021;9:652. [PMID: 34200989 DOI: 10.3390/biomedicines9060652] [Reference Citation Analysis]
60 Chen PW, Tsai ZY, Chao TH, Li YH, Hou CJ, Liu PY. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021;37:355-64. [PMID: 34257485 DOI: 10.6515/ACS.202107_37(4).20210628A] [Cited by in F6Publishing: 2] [Reference Citation Analysis]